Chemical and Pharmaceutical Bulletin p. 928 - 938 (1999)
Update date:2022-07-30
Topics:
Shiota, Takeshi
Yamamori, Teruo
Sakai, Katsunori
Kiyokawa, Mitsugu
Honma, Tsunetoshi
Ogawa, Masayoshi
Hayashi, Kunio
Ishizuka, Natsuki
Matsumura, Ken-Ichi
Hara, Mariko
Fujimoto, Masafumi
Kawabata, Tomoji
Nakajima, Shigeyuki
We have already reported 7-oxo-4,7-dihydropyrazolo[1,5-α]pyrimidine-3- carboxylic acid derivatives, which are potent in vitro angiotensin II (AII) antagonists, but have no oral antihypertensive activity. Removal of the carboxylic acid and replacement of t
View MoreTianjin Bright Future Technology Co., Ltd
Contact:0086-22-58016666
Address:NO.136 DongTeng Lake Street Tianjin Economic and Technology Development Area,Tainjin,China
ShangHai Soyoung Biotechnology Inc
website:http://www.soyoungbio.com
Contact:+86-21-69893009
Address:shanghai
website:http://www.apeptides.com/en/
Contact:+86-21-60871011
Address:No. 80 Chuanshan Shuyuan Steet,Pudong,Shanghai
Hubei Onward Bio-Development Co., Ltd.
Contact:+86-718-8417012
Address:No.517,Shizhou Avenue,Enshi City,Hubei Province,China,445002
Taizhou Chemedir Biopharm-tech Co., Ltd
Contact:+86 523 86200218
Address:G09, No. 1 Avenue China Medical City, Taizhou,Jiangsu, China
Doi:10.1002/recl.19871060401
(1987)Doi:10.1016/S0040-4020(01)81669-0
(1987)Doi:10.1021/ol802828d
(2009)Doi:10.1016/j.jfluchem.2008.04.003
(2008)Doi:10.1007/s10600-008-9126-8
(2008)Doi:10.3390/molecules16086634
(2011)